CRI Voices:戊型肝炎疫苗来了(1)

英语自学网

2012021092620779_328_o12.jpg

■中国国际广播之声（CRI）是中国向全世界广播的国家广播之声。其宗旨是“向世界介绍中国，向中国介绍世界，向世界报道世界，增进中国人民与世界人民之间的了解和友谊”。
■本节目听写包罗万千，涉及经济，政治，科学，文化等，皆在提高沪友听力水平，增进知识，何乐而不为？
参与方式：全文听写
Hints:
The hepatitis E
hepatitis A
anorexia
Xiamen
China's Fujian Province
Gao Yongzhong
Xiamen Innovax Biotech Co. Ltd
Xiamen University
China's Ministry of Science and Technology

sub_412.gif

btn_listen1974112.gif

The hepatitis E virus shares similar symptoms with hepatitis A, both of which cause victims to suffer from anorexia, vomiting and nausea. In China, the incidence rate of hepatitis E has increased notably, becoming the most common among all types of the hepatitis virus to infect adults.
Recently, a team of researchers in Xiamen, southeast China's Fujian Province, announced that they have successfully developed the world's first hepatitis E vaccine. With each injection only costing a few hundred yuan, Gao Yongzhong, general manager of Xiamen Innovax Biotech Co. Ltd, emphasizes the cheapness of the injection compared to the alternative of spending as much as 20,000 yuan on medical treatment once someone has become infected.
"In the past, people infected with hepatitis E had to receive medical treatment that would usually cost them around 20,000 yuan. But a vaccine that costs several hundred yuan will help to prevent you against infection. It is a product that has a good performance but a relatively low price."
Alongside Gao Yongzhong's company, a team of researchers from Xiamen University worked for 14 years developing the vaccine. China's Ministry of Science and Technology began to sponsor the research in 2005 under the government-funded 863 program, a high-tech development initiative.